We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
Cap. Flow
+$73.4M
Cap. Flow %
1.52%
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$48.8M
2
CMCSA icon
Comcast
CMCSA
+$46.9M
3
AVY icon
Avery Dennison
AVY
+$38.5M
4
MIDD icon
Middleby
MIDD
+$33M
5
LKQ icon
LKQ Corp
LKQ
+$32.3M

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$63.1M
2
TROW icon
T. Rowe Price
TROW
+$47.7M
3
ISRG icon
Intuitive Surgical
ISRG
+$39M
4
PAA icon
Plains All American Pipeline
PAA
+$39M
5
SHW icon
Sherwin-Williams
SHW
+$38.5M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.65%
2 Financials 14.81%
3 Industrials 14.31%
4 Technology 11.57%
5 Energy 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INTC icon
126
Intel
INTC
$487B
$4M 0.08%
174,652
+3,401
+2% +$78.3K
MJN
127
DELISTED
Mead Johnson Nutrition Company
MJN
$3.99M 0.08%
53,723
+15,340
+40% +$1.15M
IMAX icon
128
IMAX
IMAX
$2.85B
$3.92M 0.08%
129,666
+22,642
+21% +$609K
ABB
129
DELISTED
ABB Ltd
ABB
$3.8M 0.08%
161,273
+27,642
+21% +$623K
IWM icon
130
iShares Russell 2000 ETF
IWM
$81.9B
$3.61M 0.07%
33,870
+73
+0.2% +$7.55K
CME icon
131
CME Group
CME
$101B
$3.53M 0.07%
47,738
-6,455
-12% -$476K
CPRI icon
132
Capri Holdings
CPRI
$1.5B
$3.49M 0.07%
46,781
+20,923
+81% +$1.46M
PCOM
133
DELISTED
Points.com Inc. Common Shares
PCOM
$3.45M 0.07%
149,183
+24,066
+19% +$540K
LAZ icon
134
Lazard
LAZ
$4.21B
$3.27M 0.07%
90,935
-8,749
-9% -$310K
IVZ icon
135
Invesco
IVZ
$14.7B
$3.22M 0.07%
100,929
+54,571
+118% +$1.74M
DATA
136
DELISTED
Tableau Software, Inc.
DATA
$3.09M 0.06%
43,405
+15,515
+56% +$997K
LULU icon
137
lululemon athletica
LULU
$13.1B
$3.09M 0.06%
+42,195
New +$2.94M
EEM icon
138
iShares MSCI Emerging Markets ETF
EEM
$31.4B
$3M 0.06%
73,641
-3,595
-5% -$142K
T icon
139
AT&T
T
$174B
$2.98M 0.06%
116,774
-2,109
-2% -$55.4K
LUX
140
DELISTED
Luxottica Group
LUX
$2.97M 0.06%
56,552
+9,342
+20% +$497K
QCOM icon
141
Qualcomm
QCOM
$176B
$2.96M 0.06%
43,979
-160,658
-79% -$10.5M
MSFT icon
142
Microsoft
MSFT
$3.75T
$2.94M 0.06%
88,299
+638
+0.7% +$21K
ICLR icon
143
Icon
ICLR
$13.1B
$2.91M 0.06%
71,069
+34,448
+94% +$1.33M
WFC icon
144
Wells Fargo
WFC
$257B
$2.89M 0.06%
69,876
+289
+0.4% +$12.3K
SYT
145
DELISTED
Syngenta Ag
SYT
$2.85M 0.06%
35,053
-9,720
-22% -$780K
LVS icon
146
Las Vegas Sands
LVS
$28.7B
$2.72M 0.06%
40,998
+10,980
+37% +$636K
PCYC
147
DELISTED
PHARMACYCLICS INC
PCYC
$2.71M 0.06%
+19,595
New +$2.17M
TRIB
148
Trinity Biotech
TRIB
$7.93M
$2.68M 0.06%
820
+132
+19% +$386K
SIG icon
149
Signet Jewelers
SIG
$3.18B
$2.67M 0.06%
37,292
+17,329
+87% +$1.23M
RTX icon
150
RTX Corp
RTX
$286B
$2.63M 0.05%
38,737
+202
+0.5% +$13.2K
4 5
6
7 8

Similar funds

CAM
Capstone Asset Management Houston, Texas $3.6B AUM 20.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
DL
Delta Lloyd Amsterdam, Netherlands $3.56B AUM 18.98% 1-Year Est. Return
RBC
Ronald Blue & Co Roswell, Georgia $3.1B AUM 12.82% 1-Year Est. Return
TCM
Tetrem Capital Management Winnipeg, Manitoba, Canada $2.29B AUM 16.55% 1-Year Est. Return
HCM
Holland Capital Management Chicago, Illinois $2.28B AUM 23.08% 1-Year Est. Return
AL
Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return
AT
Alliance Trust Dundee, Scotland, United Kingdom $1.81B AUM 5.04% 1-Year Est. Return

Geneva Advisors's Q3 2013 Portfolio in Review

As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
  • Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
  • Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
  • Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
  • Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
  • Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
  • Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.

Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.